195 related articles for article (PubMed ID: 27583434)
1. Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Hu B; Arpag S; Zhang X; Möbius W; Werner H; Sosinsky G; Ellisman M; Zhang Y; Hamilton A; Chernoff J; Li J
PLoS Genet; 2016 Sep; 12(9):e1006290. PubMed ID: 27583434
[TBL] [Abstract][Full Text] [Related]
2. Abnormal junctions and permeability of myelin in PMP22-deficient nerves.
Guo J; Wang L; Zhang Y; Wu J; Arpag S; Hu B; Imhof BA; Tian X; Carter BD; Suter U; Li J
Ann Neurol; 2014 Feb; 75(2):255-65. PubMed ID: 24339129
[TBL] [Abstract][Full Text] [Related]
3. Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves.
Pantera H; Hu B; Moiseev D; Dunham C; Rashid J; Moran JJ; Krentz K; Rubinstein CD; Won S; Li J; Svaren J
Hum Mol Genet; 2020 Jun; 29(10):1689-1699. PubMed ID: 32356557
[TBL] [Abstract][Full Text] [Related]
4. A dual role for Integrin α6β4 in modulating hereditary neuropathy with liability to pressure palsies.
Poitelon Y; Matafora V; Silvestri N; Zambroni D; McGarry C; Serghany N; Rush T; Vizzuso D; Court FA; Bachi A; Wrabetz L; Feltri ML
J Neurochem; 2018 May; 145(3):245-257. PubMed ID: 29315582
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy.
Adlkofer K; Frei R; Neuberg DH; Zielasek J; Toyka KV; Suter U
J Neurosci; 1997 Jun; 17(12):4662-71. PubMed ID: 9169527
[TBL] [Abstract][Full Text] [Related]
6. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
Adlkofer K; Martini R; Aguzzi A; Zielasek J; Toyka KV; Suter U
Nat Genet; 1995 Nov; 11(3):274-80. PubMed ID: 7581450
[TBL] [Abstract][Full Text] [Related]
7. [Hereditary neuropathy with liability to pressure palsies: study of six Spanish families].
Pou Serradell A; Monells J; Téllez MJ; Fossas P; Löfgren A; Meuleman J; Timmerman V; De Jonghe P; Ceuterick C; Martin JJ
Rev Neurol (Paris); 2002 May; 158(5 Pt 1):579-88. PubMed ID: 12072826
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular genetic characteristics of 24 families of hereditary neuropathy with liability to pressure palsy and literature review.
Cao W; Huang S; Zhao H; Li Z; Zhu X; Liu L; Zhang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1572-1582. PubMed ID: 38432886
[TBL] [Abstract][Full Text] [Related]
9. A Case of Severe Early-Onset Neuropathy Caused by a Compound Heterozygous Deletion of the PMP22 Gene: Clinical and Neurographic Aspects.
D'Arrigo S; Tessarollo V; Taroni F; Baratta S; Pantaleoni C; Schiaffi E; Ciano C
Neuropediatrics; 2020 Jun; 51(3):173-177. PubMed ID: 31784971
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of peripheral myelin protein 22 for nerve compression and neural regeneration: a review.
Hui-Chou HG; Hashemi SS; Hoke A; Dellon AL
J Reconstr Microsurg; 2011 Jan; 27(1):67-74. PubMed ID: 20976668
[TBL] [Abstract][Full Text] [Related]
11. Hereditary neuropathy with liability to pressure palsy (HNPP): report of a family with a new point mutation in PMP22 gene.
Fusco C; Spagnoli C; Salerno GG; Pavlidis E; Frattini D; Pisani F
Ital J Pediatr; 2017 Oct; 43(1):97. PubMed ID: 29078790
[TBL] [Abstract][Full Text] [Related]
12. Frequency of hereditary neuropathy with liability to pressure palsies (HNPP) due to 17p11.2 deletion in a Korean newborn population.
Park JE; Noh SJ; Oh M; Cho DY; Kim SY; Ki CS
Orphanet J Rare Dis; 2018 Mar; 13(1):40. PubMed ID: 29544507
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of Greek patients with suspected hereditary neuropathy with liability to pressure palsies (HNPP): a 15-year experience.
Karadima G; Koutsis G; Raftopoulou M; Karletidi KM; Zambelis T; Karandreas N; Panas M
J Peripher Nerv Syst; 2015 Jun; 20(2):79-85. PubMed ID: 26110377
[TBL] [Abstract][Full Text] [Related]
14. Overlap phenotype between CMT1A and hereditary neuropathy with liability to pressure palsies caused by the novel small in-frame deletion c.407_418del12 in PMP22 gene.
Vill K; Kuhn M; Gläser D; Müller-Felber W
Neuropediatrics; 2015 Feb; 46(1):44-8. PubMed ID: 25265422
[TBL] [Abstract][Full Text] [Related]
15. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the clinical, electrophysiological and genetic features of a family affected with hereditary neuropathy with liability to pressure palsies].
Qi F; Che F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb; 32(1):31-5. PubMed ID: 25636095
[TBL] [Abstract][Full Text] [Related]
17. Dosage effects of PMP22 on nonmyelinating Schwann cells in hereditary neuropathy with liability to pressure palsies.
Koike H; Furukawa S; Mouri N; Fukami Y; Iijima M; Katsuno M
Neuromuscul Disord; 2022 Jun; 32(6):503-511. PubMed ID: 35501275
[TBL] [Abstract][Full Text] [Related]
18. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele.
Adlkofer K; Naef R; Suter U
J Neurosci Res; 1997 Sep; 49(6):671-80. PubMed ID: 9335255
[TBL] [Abstract][Full Text] [Related]
19. Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation.
Yurrebaso I; Casado OL; Barcena J; Perez de Nanclares G; Aguirre U
Neuromuscul Disord; 2014 Jan; 24(1):56-62. PubMed ID: 24239057
[TBL] [Abstract][Full Text] [Related]
20. Yield of the PMP22 deletion analysis in patients with compression neuropathies.
Ivanovic V; Brankovic M; Bjelica B; Kacar A; Tubic R; Jankovic M; Marjanovic A; Novakovic I; Rakocevic-Stojanovic V; Peric S
J Neurol; 2020 Dec; 267(12):3617-3623. PubMed ID: 32642785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
